SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001185185-18-001278
Filing Date
2018-07-25
Accepted
2018-07-25 16:31:06
Documents
2
Period of Report
2018-07-19
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K biostar8k072518.htm 8-K 20463
2 EX-99.1 ex99-1.htm EX-99 6500
  Complete submission text file 0001185185-18-001278.txt   28195
Mailing Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046
Business Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046 011-86-29-33686638
Biostar Pharmaceuticals, Inc. (Filer) CIK: 0001418133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34708 | Film No.: 18969018
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1